Research Article
Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
Table 2
Initial clinical stage of patients by receptor type.
| |||||||||||||||||||||||||||||||||||||||